Azenta, Inc. Reports Second Quarter Fiscal 2026 Results: Key Highlights and Investor Insights

Executive Summary

On May 5, 2026, Azenta, Inc. (Nasdaq: AZTA) announced its financial results for the second quarter of fiscal year 2026, ended March 31, 2026. The company also updated its long-range plan and outlook for the remainder of the fiscal year. The report included several key operational, strategic, and financial developments that are likely to be of significant interest to investors and may impact the company’s share price.

Key Financial Highlights

• Revenue from Continuing Operations: The company reported quarterly revenue (numbers not fully visible in excerpt, but financial tables confirm continued reporting). Investors should watch for quarterly and year-over-year comparisons, especially in light of challenging market conditions.
• Net Loss from Continuing Operations: For the quarter ended March 31, 2026, Azenta reported a net loss from continuing operations of \$(157.0) million, with a diluted net loss per share of \$(3.49). This marks a substantial swing from the prior year, which will concern shareholders and likely affect the share price.
• Adjusted Non-GAAP Earnings: The company’s adjustments for non-GAAP measures included amortization of intangibles, restructuring charges, and tax adjustments. After these adjustments, Azenta posted a non-GAAP adjusted net income from continuing operations (excluding stock-based compensation) of \$3.7 million for the quarter.
• Operating Cash Flow and Free Cash Flow: Operating cash flow was \$12 million for the quarter, with capital expenditures of \$7 million, resulting in free cash flow of \$5 million.

Strategic and Operational Updates

• Share Repurchase Program: On December 8, 2025, the Board authorized a \$250 million share repurchase program, running through December 31, 2028. The company can repurchase shares in the open market, privately negotiated transactions, or under Rule 10b5-1 plans. This is a significant capital allocation decision that supports shareholder value and may provide downside protection to the share price.
• Long-Range Plan Extension: With the revised 2026 outlook, Azenta is extending its long-range plan by one year, now targeting 2029 for its multi-year financial goals. The company reaffirms its commitment to market opportunities and strategic priorities, but the extension reflects a more cautious outlook.
• Free Cash Flow Guidance: The company now expects free cash flow improvement of approximately 10–15% year-over-year, down from the prior expectation of around 30% improvement. This downward revision is noteworthy and may be viewed negatively by the market.
• Sale of B Medical Systems: Azenta is progressing with the divestiture of B Medical Systems. However, there is uncertainty regarding the timing and completion of this transaction, which could impact future results.

Other Notable Items

• Balance Sheet Strength: As of March 31, 2026, Azenta reported total assets of approximately \$1.9 billion and total stockholders’ equity of around \$1.55 billion. The company maintains a strong cash and marketable securities position.
• Impairments and Charges: The quarter included restructuring charges and other one-time costs. Management urges investors to consider non-GAAP results for a clearer view of ongoing operations.
• Conference Call and Webcast: Azenta will host an earnings call on May 6, 2026, at 8:30 a.m. ET to discuss results and outlook, with webcast and materials available on the investor relations website.

Forward-Looking Statements and Risks

Azenta’s management has issued forward-looking statements regarding revenue, earnings, adjusted EBITDA margin, free cash flow, and the timing/benefits of operational initiatives. The company cautions that these are subject to significant risks, including execution risks, market demand shifts, macroeconomic and geopolitical developments, supply chain disruptions, competitive pressures, and the outcome of the B Medical Systems divestiture.

Investors are reminded that actual results may differ materially from these projections, and Azenta disclaims any obligation to update forward-looking statements except as required by law.

Summary for Shareholders

• The larger-than-expected net loss and lowered free cash flow guidance are material negatives that could weigh on the share price.
• The share repurchase program and strong cash position provide some offsetting positives, supporting valuation.
• The extension of the long-range plan and uncertainty around asset sales introduce execution risk.
• Investors should closely watch management’s commentary on the earnings call for additional details and forward-looking guidance.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Forward-looking statements are subject to risks and uncertainties. Investors should review official company filings and consult with a financial advisor before making investment decisions.

View Azenta, Inc. Historical chart here